What Researchers Did
Researchers investigated how hyperbaric oxygen therapy affects cognitive problems after a stroke, also looking at changes in specific genes and inflammatory markers in the blood.
What They Found
Patients receiving hyperbaric oxygen (HBO) therapy showed higher cognitive scores at 6 months compared to those receiving conventional treatment. The HBO group also had higher levels of anti-inflammatory factors (IL-4, IL-10) and lower levels of pro-inflammatory factors (IL-2, IL-6, TNF-α, IFN-α, IL-17A) in their blood. The study identified a specific gene network, LINC00205-hsa-miR-495-3p-TNFSF15, that may be involved in how HBO therapy works.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy could offer a way to improve cognitive function for Canadian patients recovering from a stroke. By reducing inflammation and influencing specific gene pathways, HBOT may help restore mental clarity and overall brain health after a stroke. This could lead to better long-term recovery outcomes for individuals experiencing post-stroke cognitive impairment.
Canadian Relevance
No direct Canadian connection identified. Post-stroke cognitive impairment is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The abstract does not specify the exact hyperbaric oxygen therapy protocol used, such as the pressure (ATA) or number of sessions.